TreeWAS – Variant ID: rs1512060

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
M17.1 Other primary gonarthrosis	0.019	0.981	0.000
R63.4 Abnormal weight loss	0.000	0.983	0.017
I34.0 Mitral (valve) insufficiency	0.000	0.985	0.015
R63 Symptoms and signs concerning food and fluid intake	0.000	0.991	0.009
K82.8 Other specified diseases of gallbladder	0.008	0.992	0.000
K82 Other diseases of gallbladder	0.008	0.992	0.000
I34 Nonrheumatic mitral valve disorders	0.000	0.992	0.008
I51.8 Other ill-defined heart diseases	0.000	0.992	0.008
I51.7 Cardiomegaly	0.000	0.993	0.007
K82.4 Cholesterolosis of gallbladder	0.007	0.993	0.000
I51 Complications and ill-defined descriptions of heart disease	0.000	0.993	0.007
R63.8 Other symptoms and signs concerning food and fluid intake	0.000	0.993	0.007
K82.9 Disease of gallbladder, unspecified	0.007	0.993	0.000
I51.9 Heart disease, unspecified	0.000	0.993	0.007
R63.1 Polydipsia	0.000	0.993	0.007
R63.6 Insufficient intake of food and water due to self neglect	0.000	0.993	0.007
R63.5 Abnormal weight gain	0.000	0.993	0.007
R63.3 Feeding difficulties and mismanagement	0.000	0.993	0.007
R63.2 Polyphagia	0.000	0.993	0.007
R63.0 Anorexia	0.000	0.994	0.006
Z02.8 Other examinations for administrative purposes	0.000	0.994	0.006
K82.3 Fistula of gallbladder	0.006	0.994	0.000
K82.2 Perforation of gallbladder	0.006	0.994	0.000
K82.1 Hydrops of gallbladder	0.006	0.994	0.000
K82.0 Obstruction of gallbladder	0.006	0.994	0.000
K80-K87 Disorders of gallbladder, biliary tract and pancreas	0.006	0.994	0.000
I34.9 Nonrheumatic mitral valve disorder, unspecified	0.000	0.994	0.006
I34.8 Other nonrheumatic mitral valve disorders	0.000	0.994	0.006
I34.2 Nonrheumatic mitral (valve) stenosis	0.000	0.994	0.006
I51.5 Myocardial degeneration	0.000	0.994	0.005
I51.4 Myocarditis, unspecified	0.000	0.994	0.005
I51.3 Intracardiac thrombosis, not elsewhere classified	0.000	0.994	0.005
I51.2 Rupture of papillary muscle, not elsewhere classified	0.000	0.994	0.005
I51.1 Rupture of chordae tendineae, not elsewhere classified	0.000	0.994	0.005
K81 Cholecystitis	0.005	0.995	0.000
K83 Other diseases of biliary tract	0.005	0.995	0.000
K81.0 Acute cholecystitis	0.005	0.995	0.000
K83.1 Obstruction of bile duct	0.005	0.995	0.000
K85 Acute pancreatitis	0.005	0.995	0.000
K81.1 Chronic cholecystitis	0.005	0.995	0.000
I51.6 Cardiovascular disease, unspecified	0.000	0.995	0.005
I51.0 Cardiac septal defect, acquired	0.000	0.995	0.005
Z95.1 Presence of aortocoronary bypass graft	0.000	0.995	0.005
Y42.5 Other oestrogens and progestogens	0.005	0.995	0.000
K87 Disorders of gallbladder, biliary tract and pancreas in diseases classified elsewhere	0.004	0.995	0.000
I30-I52 Other forms of heart disease	0.000	0.995	0.005
K85.1 Biliary acute pancreatitis	0.004	0.996	0.000
F31.9 Bipolar affective disorder, unspecified	0.004	0.996	0.000
K83.8 Other specified diseases of biliary tract	0.004	0.996	0.000
I50 Heart failure	0.000	0.996	0.004
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.004	0.996	0.000
I34.1 Mitral (valve) prolapse	0.000	0.996	0.004
K86 Other diseases of pancreas	0.004	0.996	0.000
B96.5 Pseudomonas (aeruginosa)(mallei)(pseudomallei) as the cause of diseases classified to other chapters	0.004	0.996	0.000
K80.5 Calculus of bile duct without cholangitis or cholecystitis	0.004	0.996	0.000
K81.8 Other cholecystitis	0.004	0.996	0.000
K83.9 Disease of biliary tract, unspecified	0.004	0.996	0.000
K83.5 Biliary cyst	0.004	0.996	0.000
K83.4 Spasm of sphincter of Oddi	0.004	0.996	0.000
K83.3 Fistula of bile duct	0.004	0.996	0.000
K83.2 Perforation of bile duct	0.004	0.996	0.000
I50.0 Congestive heart failure	0.000	0.996	0.004
I33 Acute and subacute endocarditis	0.000	0.996	0.004
K80 Cholelithiasis	0.004	0.996	0.000
K83.0 Cholangitis	0.004	0.996	0.000
Y40.9 Systemic antibiotic, unspecified	0.004	0.996	0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.004	0.996	0.000
B96 Other bacterial agents as the cause of diseases classified to other chapters	0.004	0.996	0.000
B96.2 Escherichia coli [E. coli] as the cause of diseases classified to other chapters	0.004	0.996	0.000
I47 Paroxysmal tachycardia	0.000	0.996	0.004
Y40 Systemic antibiotics	0.004	0.996	0.000
I33.0 Acute and subacute infective endocarditis	0.000	0.996	0.004
K85.8 Other acute pancreatitis	0.004	0.996	0.000
K85.3 Drug-induced acute pancreatitis	0.004	0.996	0.000
K85.2 Alcohol-induced acute pancreatitis	0.004	0.996	0.000
K85.0 Idiopathic acute pancreatitis	0.004	0.996	0.000
I47.2 Ventricular tachycardia	0.000	0.996	0.004
B96.8 Other specified bacterial agents as the cause of diseases classified to other chapters	0.004	0.996	0.000
I50.9 Heart failure, unspecified	0.000	0.996	0.004
S68.1 Traumatic amputation of other single finger (complete)(partial)	0.004	0.996	0.000
K86.9 Disease of pancreas, unspecified	0.004	0.996	0.000
F31 Bipolar affective disorder	0.004	0.996	0.000
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified	0.003	0.996	0.000
K87.1 Disorders of pancreas in diseases classified elsewhere	0.003	0.996	0.000
K87.0 Disorders of gallbladder and biliary tract in diseases classified elsewhere	0.003	0.996	0.000
I52 Other heart disorders in diseases classified elsewhere	0.000	0.996	0.003
I48 Atrial fibrillation and flutter	0.000	0.996	0.003
I43 Cardiomyopathy in diseases classified elsewhere	0.000	0.996	0.003
I41 Myocarditis in diseases classified elsewhere	0.000	0.996	0.003
I40 Acute myocarditis	0.000	0.996	0.003
I39 Endocarditis and heart valve disorders in diseases classified elsewhere	0.000	0.996	0.003
I37 Pulmonary valve disorders	0.000	0.996	0.003
I36 Nonrheumatic tricuspid valve disorders	0.000	0.996	0.003
I32 Pericarditis in diseases classified elsewhere	0.000	0.996	0.003
Y49 Psychotropic drugs, not elsewhere classified	0.003	0.996	0.000
Y42.0 Glucocorticoids and synthetic analogs	0.003	0.996	0.000
K85.9 Acute pancreatitis, unspecified	0.003	0.997	0.000
M17 Gonarthrosis [arthrosis of knee]	0.003	0.997	0.000
K86.2 Cyst of pancreas	0.003	0.997	0.000
I46 Cardiac arrest	0.000	0.997	0.003
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.003	0.997	0.000
K80.4 Calculus of bile duct with cholecystitis	0.003	0.997	0.000
I60.9 Subarachnoid haemorrhage, unspecified	0.003	0.997	0.000
Z95.4 Presence of other heart-valve replacement	0.000	0.997	0.003
Y42.9 Other and unspecified hormone antagonists	0.003	0.997	0.000
Y42.8 Other and unspecified hormones and their synthetic substitutes	0.003	0.997	0.000
Y42.4 Oral contraceptives	0.003	0.997	0.000
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.003	0.997	0.000
Y42.2 Antithyroid drugs	0.003	0.997	0.000
Y42.1 Thyroid hormones and substitutes	0.003	0.997	0.000
Y57 Other and unspecified drugs and medicaments	0.003	0.997	0.000
Y42.7 Androgens and anabolic congeners	0.003	0.997	0.000
Y48 Anaesthetics and therapeutic gases	0.003	0.997	0.000
I42 Cardiomyopathy	0.000	0.997	0.003
K86.3 Pseudocyst of pancreas	0.003	0.997	0.000
Y49.5 Other antipsychotics and neuroleptics	0.003	0.997	0.000
I30 Acute pericarditis	0.000	0.997	0.003
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.003	0.997	0.000
B96.1 Klebsiella pneumoniae [K. pneumoniae] as the cause of diseases classified to other chapters	0.003	0.997	0.000
F31.5 Bipolar affective disorder, current episode severe depression with psychotic symptoms	0.003	0.997	0.000
I33.9 Acute endocarditis, unspecified	0.000	0.997	0.003
Y51 Drugs primarily affecting the autonomic nervous system	0.003	0.997	0.000
K80.3 Calculus of bile duct with cholangitis	0.003	0.997	0.000
K86.8 Other specified diseases of pancreas	0.003	0.997	0.000
B96.4 Proteus (mirabilis)(morganii) as the cause of diseases classified to other chapters	0.003	0.997	0.000
K81.9 Cholecystitis, unspecified	0.003	0.997	0.000
Z95.2 Presence of prosthetic heart valve	0.000	0.997	0.003
F31.6 Bipolar affective disorder, current episode mixed	0.003	0.997	0.000
Z95 Presence of cardiac and vascular implants and grafts	0.000	0.997	0.003
B96.3 Haemophilus influenzae [H. influenzae] as the cause of diseases classified to other chapters	0.003	0.997	0.000
Y54.3 Benzothiadiazine derivatives	0.003	0.997	0.000
Y59 Other and unspecified vaccines and biological substances	0.003	0.997	0.000
Y58 Bacterial vaccines	0.003	0.997	0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.003	0.997	0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.003	0.997	0.000
Y53 Agents primarily affecting the gastro-intestinal system	0.003	0.997	0.000
Y50 Central nervous system stimulants, not elsewhere classified	0.003	0.997	0.000
Y47 Sedatives, hypnotics and antianxiety drugs	0.003	0.997	0.000
Y46 Antiepileptics and anti-Parkinsonism drugs	0.003	0.997	0.000
Y41 Other systemic anti-infectives and antiparasitics	0.003	0.997	0.000
B96.7 Clostridium perfringens [C. perfringens] as the cause of diseases classified to other chapters	0.003	0.997	0.000
B96.6 Bacillus fragilis [B. fragilis] as the cause of diseases classified to other chapters	0.003	0.997	0.000
B96.0 Mycoplasma pneumoniae [M. pneumoniae] as the cause of diseases classified to other chapters	0.003	0.997	0.000
I47.9 Paroxysmal tachycardia, unspecified	0.000	0.997	0.003
I47.0 Reentry ventricular arrhythmia	0.000	0.997	0.003
K86.1 Other chronic pancreatitis	0.003	0.997	0.000
O26.8 Other specified pregnancy-related conditions	0.003	0.997	0.000
Y40.7 Antifungal antibiotics, systemically used	0.003	0.997	0.000
Y40.6 Rifamycins	0.003	0.997	0.000
Y40.5 Aminoglycosides	0.003	0.997	0.000
Y40.4 Tetracyclines	0.003	0.997	0.000
Y40.3 Macrolides	0.003	0.997	0.000
Y40.2 Chloramphenicol group	0.003	0.997	0.000
Y40.1 Cefalosporins and other -lactam antibiotics	0.003	0.997	0.000
Y57.5 X-ray contrast media	0.003	0.997	0.000
Y40.0 Penicillins	0.003	0.997	0.000
K86.0 Alcohol-induced chronic pancreatitis	0.003	0.997	0.000
I46.9 Cardiac arrest, unspecified	0.000	0.997	0.003
I38 Endocarditis, valve unspecified	0.000	0.997	0.003
I50.1 Left ventricular failure	0.000	0.997	0.003
Y45.2 Propionic acid derivatives	0.003	0.997	0.000
Y40.8 Other systemic antibiotics	0.003	0.997	0.000
Y44 Agents primarily affecting blood constituents	0.003	0.997	0.000
Y48.3 Local anaesthetics	0.003	0.997	0.000
Z95.8 Presence of other cardiac and vascular implants and grafts	0.000	0.997	0.003
K80.0 Calculus of gallbladder with acute cholecystitis	0.003	0.997	0.000
K80.8 Other cholelithiasis	0.003	0.997	0.000
F31.8 Other bipolar affective disorders	0.003	0.997	0.000
F31.7 Bipolar affective disorder, currently in remission	0.003	0.997	0.000
F31.4 Bipolar affective disorder, current episode severe depression without psychotic symptoms	0.003	0.997	0.000
F31.3 Bipolar affective disorder, current episode mild or moderate depression	0.003	0.997	0.000
F31.2 Bipolar affective disorder, current episode manic with psychotic symptoms	0.003	0.997	0.000
Y52 Agents primarily affecting the cardiovascular system	0.003	0.997	0.000
I32.8 Pericarditis in other diseases classified elsewhere	0.000	0.997	0.003
I32.1 Pericarditis in other infectious and parasitic diseases classified elsewhere	0.000	0.997	0.003
I32.0 Pericarditis in bacterial diseases classified elsewhere	0.000	0.997	0.003
I36.9 Nonrheumatic tricuspid valve disorder, unspecified	0.000	0.997	0.003
I36.8 Other nonrheumatic tricuspid valve disorders	0.000	0.997	0.003
I36.2 Nonrheumatic tricuspid (valve) stenosis with insufficiency	0.000	0.997	0.003
I36.1 Nonrheumatic tricuspid (valve) insufficiency	0.000	0.997	0.003
I36.0 Nonrheumatic tricuspid (valve) stenosis	0.000	0.997	0.003
I37.9 Pulmonary valve disorder, unspecified	0.000	0.997	0.003
I37.8 Other pulmonary valve disorders	0.000	0.997	0.003
I37.2 Pulmonary valve stenosis with insufficiency	0.000	0.997	0.003
I37.1 Pulmonary valve insufficiency	0.000	0.997	0.003
I37.0 Pulmonary valve stenosis	0.000	0.997	0.003
I39.8 Endocarditis, valve unspecified, in diseases classified elsewhere	0.000	0.997	0.003
I39.4 Multiple valve disorders in diseases classified elsewhere	0.000	0.997	0.003
I39.3 Pulmonary valve disorders in diseases classified elsewhere	0.000	0.997	0.003
I39.2 Tricuspid valve disorders in diseases classified elsewhere	0.000	0.997	0.003
I39.1 Aortic valve disorders in diseases classified elsewhere	0.000	0.997	0.003
I39.0 Mitral valve disorders in diseases classified elsewhere	0.000	0.997	0.003
I40.9 Acute myocarditis, unspecified	0.000	0.997	0.003
I40.8 Other acute myocarditis	0.000	0.997	0.003
I40.1 Isolated myocarditis	0.000	0.997	0.003
I40.0 Infective myocarditis	0.000	0.997	0.003
I41.8 Myocarditis in other diseases classified elsewhere	0.000	0.997	0.003
I41.2 Myocarditis in other infectious and parasitic diseases classified elsewhere	0.000	0.997	0.003
I41.1 Myocarditis in viral diseases classified elsewhere	0.000	0.997	0.003
I41.0 Myocarditis in bacterial diseases classified elsewhere	0.000	0.997	0.003
I43.8 Cardiomyopathy in other diseases classified elsewhere	0.000	0.997	0.003
I43.2 Cardiomyopathy in nutritional diseases	0.000	0.997	0.003
I43.1 Cardiomyopathy in metabolic diseases	0.000	0.997	0.003
I43.0 Cardiomyopathy in infectious and parasitic diseases classified elsewhere	0.000	0.997	0.003
I48.9 Atrial fibrillation and atrial flutter, unspecified	0.000	0.997	0.003
I48.4 Atypical atrial flutter	0.000	0.997	0.003
I48.3 Typical atrial flutter	0.000	0.997	0.003
I48.2 Chronic atrial fibrillation	0.000	0.997	0.003
I48.1 Persistent atrial fibrillation	0.000	0.997	0.003
I48.0 Paroxysmal atrial fibrillation	0.000	0.997	0.003
I52.8 Other heart disorders in other diseases classified elsewhere	0.000	0.997	0.003
I52.1 Other heart disorders in other infectious and parasitic diseases classified elsewhere	0.000	0.997	0.003
I52.0 Other heart disorders in bacterial diseases classified elsewhere	0.000	0.997	0.003
Y49.9 Psychotropic drug, unspecified	0.003	0.997	0.000
Y49.8 Other psychotropic drugs, not elsewhere classified	0.003	0.997	0.000
Y49.7 Psychostimulants with abuse potential	0.003	0.997	0.000
Y49.6 Psychodysleptics [hallucinogens]	0.003	0.997	0.000
Y49.4 Butyrophenone and thioxanthene neuroleptics	0.003	0.997	0.000
Y49.3 Phenothiazine antipsychotics and neuroleptics	0.003	0.997	0.000
Y49.2 Other and unspecified antidepressants	0.003	0.997	0.000
Y49.1 Monoamine-oxidase-inhibitor antidepressants	0.003	0.997	0.000
Y49.0 Tricyclic and tetracyclic antidepressants	0.003	0.997	0.000
F31.0 Bipolar affective disorder, current episode hypomanic	0.003	0.997	0.000
M17.5 Other secondary gonarthrosis	0.003	0.997	0.000
M17.4 Other secondary gonarthrosis, bilateral	0.003	0.997	0.000
M17.2 Posttraumatic gonarthrosis, bilateral	0.003	0.997	0.000
Y54.9 Mineral salts, not elsewhere classified	0.003	0.997	0.000
Y54.8 Agents affecting uric acid metabolism	0.003	0.997	0.000
Y54.7 Agents affecting calcification	0.003	0.997	0.000
Y54.6 Electrolytic, caloric and water-balance agents	0.003	0.997	0.000
Y54.5 Other diuretics	0.003	0.997	0.000
Y54.4 Loop [high-ceiling] diuretics	0.003	0.997	0.000
Y54.2 Carbonic-anhydrase inhibitors	0.003	0.997	0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]	0.003	0.997	0.000
Y54.0 Mineralocorticoids	0.003	0.997	0.000
I46.1 Sudden cardiac death, so described	0.000	0.997	0.003
Z02 Examination and encounter for administrative purposes	0.000	0.997	0.003
I42.0 Dilated cardiomyopathy	0.000	0.997	0.003
Y57.8 Other drugs and medicaments	0.003	0.997	0.000
Y57.7 Vitamins, not elsewhere classified	0.003	0.997	0.000
Y57.6 Other diagnostic agents	0.003	0.997	0.000
Y57.4 Pharmaceutical excipients	0.003	0.997	0.000
Y57.3 Alcohol deterrents	0.003	0.997	0.000
Y57.2 Antidotes and chelating agents, not elsewhere classified	0.003	0.997	0.000
Y57.1 Lipotropic drugs	0.003	0.997	0.000
Y57.0 Appetite depressants [anorectics]	0.003	0.997	0.000
F31.1 Bipolar affective disorder, current episode manic without psychotic symptoms	0.003	0.997	0.000
I42.9 Cardiomyopathy, unspecified	0.000	0.997	0.003
M17.0 Primary gonarthrosis, bilateral	0.003	0.997	0.000
Y48.5 Therapeutic gases	0.002	0.997	0.000
Y48.4 Anaesthetic, unspecified	0.002	0.997	0.000
Y48.2 Other and unspecified general anaesthetics	0.002	0.997	0.000
Y48.1 Parenteral anaesthetics	0.002	0.997	0.000
Y48.0 Inhaled anaesthetics	0.002	0.997	0.000
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified	0.003	0.997	0.000
I31 Other diseases of pericardium	0.000	0.997	0.003
I42.8 Other cardiomyopathies	0.000	0.997	0.002
I42.7 Cardiomyopathy due to drugs and other external agents	0.000	0.997	0.002
I42.6 Alcoholic cardiomyopathy	0.000	0.997	0.002
I42.5 Other restrictive cardiomyopathy	0.000	0.997	0.002
I42.4 Endocardial fibroelastosis	0.000	0.997	0.002
I42.3 Endomyocardial (eosinophilic) disease	0.000	0.997	0.002
I30.8 Other forms of acute pericarditis	0.000	0.997	0.002
I30.1 Infective pericarditis	0.000	0.997	0.002
I30.0 Acute nonspecific idiopathic pericarditis	0.000	0.997	0.002
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified	0.002	0.997	0.000
Y45.8 Other analgesics and antipyretics	0.002	0.997	0.000
Y45.5 4-Aminophenol derivatives	0.002	0.997	0.000
Y45.4 Antirheumatics	0.002	0.997	0.000
M17.3 Other posttraumatic gonarthrosis	0.002	0.997	0.000
Z95.9 Presence of cardiac and vascular implant and graft, unspecified	0.000	0.997	0.003
Y43 Primarily systemic agents	0.003	0.997	0.000
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system	0.002	0.997	0.000
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified	0.002	0.997	0.000
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified	0.002	0.997	0.000
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.002	0.997	0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.002	0.997	0.000
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified	0.002	0.997	0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified	0.002	0.997	0.000
Y51.1 Other parasympathomimetics [cholinergics]	0.002	0.997	0.000
Y51.0 Anticholinesterase agents	0.002	0.997	0.000
Y57.9 Drug or medicament, unspecified	0.002	0.997	0.000
K80.36 Calculus of bile duct with acute and chronic cholangitis without obstruction	0.002	0.997	0.000
M25.51 Pain in joint (Shoulder region)	0.003	0.997	0.000
I42.1 Obstructive hypertrophic cardiomyopathy	0.000	0.997	0.002
Y45.1 Salicylates	0.002	0.997	0.000
Y45.0 Opioids and related analgesics	0.002	0.997	0.000
K80.1 Calculus of gallbladder with other cholecystitis	0.003	0.997	0.000
Y41.9 Systemic anti-infective and antiparasitic, unspecified	0.002	0.997	0.000
Y41.8 Other specified systemic anti-infectives and antiparasitics	0.002	0.997	0.000
Y41.5 Antiviral drugs	0.002	0.997	0.000
Y41.4 Anthelminthics	0.002	0.997	0.000
Y41.3 Other antiprotozoal drugs	0.002	0.997	0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa	0.002	0.997	0.000
Y41.1 Antimycobacterial drugs	0.002	0.997	0.000
Y41.0 Sulphonamides	0.002	0.997	0.000
Y46.8 Antispasticity drugs	0.002	0.997	0.000
Y46.7 Anti-Parkinsonism drugs	0.002	0.997	0.000
Y46.6 Other and unspecified antiepileptics	0.002	0.997	0.000
Y46.5 Valproic acid	0.002	0.997	0.000
Y46.4 Iminostilbenes	0.002	0.997	0.000
Y46.3 Deoxybarbiturates	0.002	0.997	0.000
Y46.2 Hydantoin derivatives	0.002	0.997	0.000
Y46.1 Oxazolidinediones	0.002	0.997	0.000
Y46.0 Succinimides	0.002	0.997	0.000
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified	0.002	0.997	0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs	0.002	0.997	0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified	0.002	0.997	0.000
Y47.4 Bromine compounds	0.002	0.997	0.000
Y47.3 Paraldehyde	0.002	0.997	0.000
Y47.2 Chloral derivatives	0.002	0.997	0.000
Y47.1 Benzodiazepines	0.002	0.997	0.000
Y47.0 Barbiturates, not elsewhere classified	0.002	0.997	0.000
Y50.9 Central nervous system stimulant, unspecified	0.002	0.997	0.000
Y50.8 Other central nervous system stimulants	0.002	0.997	0.000
Y50.2 Methylxanthines, not elsewhere classified	0.002	0.997	0.000
Y50.1 Opioid receptor antagonists	0.002	0.997	0.000
Y50.0 Analeptics	0.002	0.997	0.000
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.002	0.997	0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system	0.002	0.997	0.000
Y53.7 Emetics	0.002	0.997	0.000
Y53.6 Antidiarrhoeal drugs	0.002	0.997	0.000
Y53.5 Digestants	0.002	0.997	0.000
Y53.4 Other laxatives	0.002	0.997	0.000
Y53.3 Saline and osmotic laxatives	0.002	0.997	0.000
Y53.2 Stimulant laxatives	0.002	0.997	0.000
Y53.1 Other antacids and anti-gastric-secretion drugs	0.002	0.997	0.000
Y53.0 Histamine H2-receptor antagonists	0.002	0.997	0.000
Y55.7 Other and unspecified agents primarily acting on the respiratory system	0.002	0.997	0.000
Y55.6 Antiasthmatics, not elsewhere classified	0.002	0.997	0.000
Y55.5 Anticommon cold drugs	0.002	0.997	0.000
Y55.4 Expectorants	0.002	0.997	0.000
Y55.3 Antitussives	0.002	0.997	0.000
Y55.2 Other and unspecified agents primarily acting on muscles	0.002	0.997	0.000
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.002	0.997	0.000
Y55.0 Oxytocic drugs	0.002	0.997	0.000
Y56.9 Topical agent, unspecified	0.002	0.997	0.000
Y56.8 Other topical agents	0.002	0.997	0.000
Y56.7 Dental drugs, topically applied	0.002	0.997	0.000
Y56.6 Otorhinolaryngological drugs and preparations	0.002	0.997	0.000
Y56.5 Ophthalmological drugs and preparations	0.002	0.997	0.000
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.002	0.997	0.000
Y56.3 Emollients, demulcents and protectants	0.002	0.997	0.000
Y56.2 Local astringents and local detergents	0.002	0.997	0.000
Y56.1 Antipruritics	0.002	0.997	0.000
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.002	0.997	0.000
Y58.9 Other and unspecified bacterial vaccines	0.002	0.997	0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component	0.002	0.997	0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component	0.002	0.997	0.000
Y58.5 Diphtheria vaccine	0.002	0.997	0.000
Y58.4 Tetanus vaccine	0.002	0.997	0.000
Y58.3 Plague vaccine	0.002	0.997	0.000
Y58.2 Cholera vaccine	0.002	0.997	0.000
Y58.1 Typhoid and paratyphoid vaccine	0.002	0.997	0.000
Y58.0 BCG vaccine	0.002	0.997	0.000
Y59.9 Vaccine or biological substance, unspecified	0.002	0.997	0.000
Y59.8 Other specified vaccines and biological substances	0.002	0.997	0.000
Y59.3 Immunoglobulin	0.002	0.997	0.000
Y59.2 Protozoal vaccines	0.002	0.997	0.000
Y59.1 Rickettsial vaccines	0.002	0.997	0.000
Y59.0 Viral vaccines	0.002	0.997	0.000
K05.3 Chronic periodontitis	0.002	0.997	0.000
L40.9 Psoriasis, unspecified	0.000	0.997	0.002
O26 Maternal care for other conditions predominantly related to pregnancy	0.002	0.997	0.000
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.002	0.998	0.000
S68 Traumatic amputation of wrist and hand	0.002	0.998	0.000
I45 Other conduction disorders	0.000	0.998	0.002
I47.1 Supraventricular tachycardia	0.000	0.998	0.002
Y52.2 Other antidysrhythmic drugs, not elsewhere classified	0.002	0.998	0.000
I30.9 Acute pericarditis, unspecified	0.000	0.998	0.002
O20.9 Haemorrhage in early pregnancy, unspecified	0.002	0.998	0.000
R60.0 Localised oedema	0.002	0.998	0.000
Y44.9 Other and unspecified agents affecting blood constituents	0.002	0.998	0.000
Y44.7 Plasma substitutes	0.002	0.998	0.000
Y44.6 Natural blood and blood products	0.002	0.998	0.000
Y44.5 Thrombolytic drugs	0.002	0.998	0.000
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]	0.002	0.998	0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants	0.002	0.998	0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations	0.002	0.998	0.000
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations	0.002	0.998	0.000
I42.2 Other hypertrophic cardiomyopathy	0.000	0.998	0.002
I44 Atrioventricular and left bundle-branch block	0.000	0.998	0.002
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system	0.002	0.998	0.000
Y52.8 Antivaricose drugs, including sclerosing agents	0.002	0.998	0.000
Y52.7 Peripheral vasodilators	0.002	0.998	0.000
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.002	0.998	0.000
Y52.1 Calcium-channel blockers	0.002	0.998	0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action	0.002	0.998	0.000
M79.79 Fibromyalgia (Site unspecified)	0.002	0.998	0.000
I46.0 Cardiac arrest with successful resuscitation	0.000	0.998	0.002
Y43.4 Immunosuppressive agents	0.002	0.998	0.000
I45.9 Conduction disorder, unspecified	0.000	0.998	0.002
Z02.9 Examination for administrative purposes, unspecified	0.000	0.998	0.002
Z02.7 Issue of medical certificate	0.000	0.998	0.002
Z02.6 Examination for insurance purposes	0.000	0.998	0.002
Z02.5 Examination for participation in sport	0.000	0.998	0.002
Z02.4 Examination for driving licence	0.000	0.998	0.002
Z02.3 Examination for recruitment to armed forces	0.000	0.998	0.002
Z02.2 Examination for admission to residential institution	0.000	0.998	0.002
Z02.1 Pre-employment examination	0.000	0.998	0.002
Z02.0 Examination for admission to educational institution	0.000	0.998	0.002
F30-F39 Mood [affective] disorders	0.002	0.998	0.000
Y52.5 Other antihypertensive drugs, not elsewhere classified	0.002	0.998	0.000
I31.8 Other specified diseases of pericardium	0.000	0.998	0.002
I31.2 Haemopericardium, not elsewhere classified	0.000	0.998	0.002
I31.1 Chronic constrictive pericarditis	0.000	0.998	0.002
I31.0 Chronic adhesive pericarditis	0.000	0.998	0.002
Y52.3 Coronary vasodilators, not elsewhere classified	0.002	0.998	0.000
M25.78 Osteophyte (Other)	0.002	0.998	0.000
Y52.4 Angiotensin-converting-enzyme inhibitors	0.002	0.998	0.000
Y43.9 Primarily systemic agent, unspecified	0.002	0.998	0.000
Y43.8 Other primarily systemic agents, not elsewhere classified	0.002	0.998	0.000
Y43.6 Enzymes, not elsewhere classified	0.002	0.998	0.000
Y43.5 Acidifying and alkalising agents	0.002	0.998	0.000
Y43.2 Antineoplastic natural products	0.002	0.998	0.000
Y43.1 Antineoplastic antimetabolites	0.002	0.998	0.000
Y43.0 Antiallergic and antiemetic drugs	0.002	0.998	0.000
H36.0 Diabetic retinopathy	0.000	0.998	0.002
N94.6 Dysmenorrhoea, unspecified	0.000	0.998	0.002
O20-O29 Other maternal disorders predominantly related to pregnancy	0.002	0.998	0.000
Y44.2 Anticoagulants	0.002	0.998	0.000
I49 Other cardiac arrhythmias	0.000	0.998	0.002
I35 Nonrheumatic aortic valve disorders	0.000	0.998	0.002
O20 Haemorrhage in early pregnancy	0.002	0.998	0.000
O26.7 Subluxation of symphysis (pubis) in pregnancy, childbirth and the puerperium	0.002	0.998	0.000
O26.6 Liver disorders in pregnancy, childbirth and the puerperium	0.002	0.998	0.000
O26.5 Maternal hypotension syndrome	0.002	0.998	0.000
O26.4 Herpes gestationis	0.002	0.998	0.000
O26.3 Retained intra-uterine contraceptive device in pregnancy	0.002	0.998	0.000
O26.2 Pregnancy care of habitual aborter	0.002	0.998	0.000
O26.1 Low weight gain in pregnancy	0.002	0.998	0.000
O26.0 Excessive weight gain in pregnancy	0.002	0.998	0.000
I45.8 Other specified conduction disorders	0.000	0.998	0.002
I45.2 Bifascicular block	0.000	0.998	0.002
I45.0 Right fascicular block	0.000	0.998	0.002
S68.9 Traumatic amputation of wrist and hand, level unspecified	0.002	0.998	0.000
S68.8 Traumatic amputation of other parts of wrist and hand	0.002	0.998	0.000
S68.4 Traumatic amputation of hand at wrist level	0.002	0.998	0.000
S68.3 Combined traumatic amputation of (part of) finger(s) with other parts of wrist and hand	0.002	0.998	0.000
S68.2 Traumatic amputation of two or more fingers alone (complete)(partial)	0.002	0.998	0.000
S68.0 Traumatic amputation of thumb (complete)(partial)	0.002	0.998	0.000
F33 Recurrent depressive disorder	0.002	0.998	0.000
Z95.3 Presence of xenogenic heart valve	0.000	0.998	0.002
F30 Manic episode	0.002	0.998	0.000
O26.9 Pregnancy-related condition, unspecified	0.002	0.998	0.000
O21 Excessive vomiting in pregnancy	0.002	0.998	0.000
I45.1 Other and unspecified right bundle-branch block	0.000	0.998	0.002
I49.3 Ventricular premature depolarisation	0.000	0.998	0.002
S64.4 Injury of digital nerve of other finger	0.002	0.998	0.000
I44.6 Other and unspecified fascicular block	0.000	0.998	0.002
I44.5 Left posterior fascicular block	0.000	0.998	0.002
I44.4 Left anterior fascicular block	0.000	0.998	0.002
I44.3 Other and unspecified atrioventricular block	0.000	0.998	0.002
F33.3 Recurrent depressive disorder, current episode severe with psychotic symptoms	0.002	0.998	0.000
F33.0 Recurrent depressive disorder, current episode mild	0.002	0.998	0.000
I60.8 Other subarachnoid haemorrhage	0.002	0.998	0.000
I31.3 Pericardial effusion (noninflammatory)	0.000	0.998	0.002
I60 Subarachnoid haemorrhage	0.002	0.998	0.000
F32.3 Severe depressive episode with psychotic symptoms	0.002	0.998	0.000
O21.0 Mild hyperemesis gravidarum	0.002	0.998	0.000
S64.3 Injury of digital nerve of thumb	0.002	0.998	0.000
S64 Injury of nerves at wrist and hand level	0.002	0.998	0.000
F30.0 Hypomania	0.002	0.998	0.000
F38 Other mood [affective] disorders	0.002	0.998	0.000
F34 Persistent mood [affective] disorders	0.002	0.998	0.000
F39 Unspecified mood [affective] disorder	0.002	0.998	0.000
I44.7 Left bundle-branch block, unspecified	0.000	0.998	0.002
I45.4 Nonspecific intraventricular block	0.000	0.998	0.002
I45.3 Trifascicular block	0.000	0.998	0.002
F33.1 Recurrent depressive disorder, current episode moderate	0.002	0.998	0.000
I35.9 Aortic valve disorder, unspecified	0.000	0.998	0.002
I49.4 Other and unspecified premature depolarisation	0.000	0.998	0.002
O29 Complications of anaesthesia during pregnancy	0.002	0.998	0.000
O28 Abnormal findings on antenatal screening of mother	0.002	0.998	0.000
O23 Infections of genito-urinary tract in pregnancy	0.002	0.998	0.000
O22 Venous complications in pregnancy	0.002	0.998	0.000
O25 Malnutrition in pregnancy	0.002	0.998	0.000
I45.6 Preexcitation syndrome	0.000	0.998	0.002
I45.5 Other specified heart block	0.000	0.998	0.001
I49.2 Junctional premature depolarisation	0.000	0.998	0.002
O20.8 Other haemorrhage in early pregnancy	0.002	0.998	0.000
O67.9 Intrapartum haemorrhage, unspecified	0.002	0.998	0.000
Z95.5 Presence of coronary angioplasty implant and graft	0.000	0.998	0.002
G40.3 Generalised idiopathic epilepsy and epileptic syndromes	0.000	0.998	0.002
K61.0 Anal abscess	0.000	0.998	0.002
F33.8 Other recurrent depressive disorders	0.002	0.998	0.000
F33.4 Recurrent depressive disorder, currently in remission	0.002	0.998	0.000
I49.0 Ventricular fibrillation and flutter	0.000	0.998	0.002
O72.2 Delayed and secondary postpartum haemorrhage	0.002	0.998	0.000
M25.71 Osteophyte (Shoulder region)	0.002	0.998	0.000
F30.9 Manic episode, unspecified	0.002	0.998	0.000
F30.8 Other manic episodes	0.002	0.998	0.000
F30.2 Mania with psychotic symptoms	0.002	0.998	0.000
F30.1 Mania without psychotic symptoms	0.002	0.998	0.000
I49.8 Other specified cardiac arrhythmias	0.000	0.998	0.002
K80.2 Calculus of gallbladder without cholecystitis	0.002	0.998	0.000
O72.1 Other immediate postpartum haemorrhage	0.002	0.998	0.000
O72 Postpartum haemorrhage	0.002	0.998	0.000
F33.2 Recurrent depressive disorder, current episode severe without psychotic symptoms	0.002	0.998	0.000
H04.2 Epiphora	0.000	0.998	0.002

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations